• Boost Your Research with FREE Freezing Medium

Tumor Cell Lines

KM12C

  • For research use only

Cat No.

ABC-TC0510

Product Type

Human Colon Cancer Cell Lines

Species

Human

Growth Conditions

37 ℃, 5% CO2

Product Code

KM12 C; KM-12C; KM12C; Km12C

Tumorigenecity: Isoenzyme: Histopathology: carcinoma, low metastaticSubculture: Split ratio: Media change: Reverse transcritase: Production

Product Image

Description

KM12C is a human colorectal carcinoma cell line originally established from a Dukes’ stage B2 colon adenocarcinoma of a male patient and is a poorly metastatic derivative within the KM12 family of colon cancer cells. The cells grow as adherent epithelial-like carcinoma cells with a near-diploid karyotype and exhibit chromosomal instability (CIN), which is characteristic of the chromosomal instability pathway in colorectal tumorigenesis, distinguishing them from more aggressive metastatic derivatives such as KM12SM and KM12L4A. These features make KM12C a representative model of low metastatic colorectal carcinoma biology. Genetic and expression profiles reported for KM12C are based on published literature and database records reflecting tumor evolution and cytogenetic patterns. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV‑1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

KM12 C; KM-12C; KM12C; Km12C

Species

Human

Cat.No

ABC-TC0510

Product Category

Tumor Cell Lines

Size/Quantity

1 vial

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Colon Cancer Cell Lines

Application

  • KM12C is used as an in vitro model of human colorectal carcinoma for studies of tumor cell proliferation, chromosomal and microsatellite instability, and early tumor progression. It supports examination of genetic and cytogenetic evolution in colon cancer, comparative analyses with metastatic KM12 variants, and evaluation of anti‑cancer agents in preclinical CRC research.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring KM12C

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button